Somatostatin Analogues for Neuroendocrine Cancer: Lanreotide and Octreotide

Updated and reviewed 15th January 2025. Somatostatin Analogues are the ‘workhorse’ treatments for those living with NETs, particularly where certain syndromes are involved.  So not just for classic NETs with Carcinoid Syndrome but also for treating the hormone over secretions caused by insulinoma, gastrinoma, glucagonoma and VIPoma (all types of pNETs) and others. They are most effective … Continue reading Somatostatin Analogues for Neuroendocrine Cancer: Lanreotide and Octreotide